摘要
目的分析我院门诊注射用腺苷钻胺的临床使用情况,探讨其用药合理性。方法利用PASS软件随机抽取我院信息管理系统2015年1月-2015年12月期间门诊患者注射用腺苷钻胺的使用处方记录5000份,参照《医院处方点评管理规范》以及注射用腺苷钻胺的说明书和相关指南文献对处方的合理性进行点评分析。结果在随机抽取的5000份处方中,不合理处方1764份,占处方总数的35.28%。其中,无适应症用药处方903份,占不合理处方总数的51.13%;门诊处方超过7日用量且特殊情况下需要适当延长处方用量未注明理由处方810份,占不合理处方总数的45.92%;用法用量不适宜的处方150份,占不合理处方的8.5%。结论应加强注射用腺苷钻胺在临床的合理使用,提高治疗效果,减少不良反应的发生。
Objective To analyze the reasonableness of Cobamamide for Injection in clinic. Methods 5000 prescriptions containing Cobamamide for Injection were selected from our information management system during January-December of 2015 by PASS system at random. With reference to the Hospital Prescription Comment on Standardized Management, the illustration of Cobamamide, and the related guides and literatures, the data of the prescriptions of Cobamamide for Injection in 5000 outpatients were analyzed. Results Of the total 5000 outpatient prescriptions, 1764 were irrational,accounting for 35.28% of total. 903 were not indications for drug use（51.13%）, 810 were with dosage more than 7 days including some special cases need to extend but not indicated（accounting for 45.92% of the total irrational prescriptions）, and 150 were inappropriate dosage or usage（8.50%）. Conclusion Clinical rational use of Cobamamide for Injection should be strengthened in order to improve the efficacy and reduce the adverse drug reaction.
出处
《首都食品与医药》
2016年第6期57-59,共3页
Capital Food Medicine
关键词
注射用腺苷钴胺
处方点评
不合理处方
Cobamamide for Injection
Prescription comment
Irrational prescription
